title: Quantifying the effects of renal impairment on plasma concentrations of the neuroendocrine neoplasia biomarkers chromogranin A, chromogranin B, and cocaine- and amphetamine-regulated transcript.
authors.forename: Paul R
authors.initials: PR
authors.lastname: Bech
authors.forename: Radha
authors.initials: R
authors.lastname: Ramachandran
authors.forename: Waljit S
authors.initials: WS
authors.lastname: Dhillo
authors.forename: Niamh M
authors.initials: NM
authors.lastname: Martin
authors.forename: Stephen R
authors.initials: SR
authors.lastname: Bloom
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood*; D016022:Case-Control Studies; D053379:Chromogranin A / Q000097:blood*; D053378:Chromogranin B / Q000097:blood*; D005919:Glomerular Filtration Rate; D006801:Humans; D009419:Nerve Tissue Proteins / Q000097:blood*; D018358:Neuroendocrine Tumors / Q000097:blood* / Q000175:diagnosis; D051437:Renal Insufficiency / Q000097:blood / Q000503:physiopathology; D051436:Renal Insufficiency, Chronic / Q000097:blood* / Q000503:physiopathology; D012680:Sensitivity and Specificity; D000098882:Cocaine- and Amphetamine-Regulated Transcript Protein
chemical_list: D014408:Biomarkers, Tumor; D053379:Chromogranin A; D053378:Chromogranin B; D009419:Nerve Tissue Proteins; D000098882:Cocaine- and Amphetamine-Regulated Transcript Protein